H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.
作者信息
Leary Peter J, Hess Edward, Barón Anna E, Branch Kelley R, Choudhary Gaurav, Hough Catherine L, Maron Bradley A, Ralph David D, Ryan John J, Tedford Ryan J, Weiss Noel S, Zamanian Roham T, Lahm Tim
机构信息
1 University of Washington Seattle, Washington.
2 Veterans Affairs Eastern Colorado Health Care System Denver, Colorado.
出版信息
Am J Respir Crit Care Med. 2018 Jun 15;197(12):1638-1641. doi: 10.1164/rccm.201801-0048LE.
Abstract
摘要
相似文献
1
H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.H2受体拮抗剂在肺动脉高压中的应用与死亡率：来自退伍军人事务部临床评估、报告与跟踪（VA-CART）项目的见解
Am J Respir Crit Care Med. 2018 Jun 15;197(12):1638-1641. doi: 10.1164/rccm.201801-0048LE.
2
[Effect of blocking receptors mediating histamine H2 in human pulmonary circulation].[组胺H2受体阻断剂对人体肺循环的影响]
Arch Inst Cardiol Mex. 1980 Jan-Feb;50(1):65-8.
3
Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.质子泵抑制剂使用者的死亡风险：一项针对美国退伍军人的纵向观察队列研究。
BMJ Open. 2017 Jul 4;7(6):e015735. doi: 10.1136/bmjopen-2016-015735.
4
[The effects of an H2 receptor antagonist (cimetidine) in asthmatic patients].[H2受体拮抗剂（西咪替丁）对哮喘患者的影响]
Arerugi. 1985 Jan;34(1):23-32.
5
Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy.与组胺H2受体拮抗剂治疗相关的血栓性血小板减少性紫癜。
West J Med. 1996 May;164(5):446-8.
6
Histamine-2-receptor antagonists and gastric cancer risk.组胺-2受体拮抗剂与胃癌风险
Lancet. 1990 Aug 11;336(8711):355-7. doi: 10.1016/0140-6736(90)91888-h.
7
Histamine H2-receptor antagonists.组胺H2受体拮抗剂
Nurs Clin North Am. 1991 Jun;26(2):361-73.
8
Comment: effects and side effects of H1- and H2-receptor antagonists in clinical situations.评论：H1和H2受体拮抗剂在临床情况下的作用及副作用。
Klin Wochenschr. 1982 Sep 1;60(17):1046-7. doi: 10.1007/BF01716969.
9
[Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].[法莫替丁。新型组胺H2受体拮抗剂的药理及临床概况]
Fortschr Med. 1986 Apr 17;104(15):319-22.
10
引用本文的文献
1
Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled Trial.法莫替丁对肺动脉高压患者预后的影响：一项随机对照试验。
Chest. 2025 Jul;168(1):189-199. doi: 10.1016/j.chest.2024.12.029. Epub 2025 Jan 4.
2
Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle.心脏重塑中的肥大细胞：聚焦于右心室
J Cardiovasc Dev Dis. 2024 Feb 4;11(2):54. doi: 10.3390/jcdd11020054.
3
Associations of Histamine Metabolites with Disease Severity and Mortality in Pulmonary Arterial Hypertension.组胺代谢产物与肺动脉高压疾病严重程度及死亡率的关联
Ann Am Thorac Soc. 2023 Nov;20(11):1676-1679. doi: 10.1513/AnnalsATS.202304-302RL.
4
Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.与肺动脉高压结局相关的代谢组学特征。
Circ Res. 2023 Feb 3;132(3):254-266. doi: 10.1161/CIRCRESAHA.122.321923. Epub 2023 Jan 4.
5
Histamine H Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women's Health Initiative.组胺 H 受体拮抗剂与绝经后妇女心力衰竭风险：女性健康倡议。
J Am Heart Assoc. 2022 Mar;11(5):e024270. doi: 10.1161/JAHA.121.024270. Epub 2022 Feb 22.
6
The Roles of Cardiovascular H-Histamine Receptors Under Normal and Pathophysiological Conditions.正常及病理生理条件下心血管H-组胺受体的作用
Front Pharmacol. 2021 Dec 20;12:732842. doi: 10.3389/fphar.2021.732842. eCollection 2021.
7
Pulmonary arterial hypertension: Rationale for using multiple vs. single drug therapy.肺动脉高压：联合用药与单药治疗的理论依据
Glob Cardiol Sci Pract. 2020 Apr 30;2020(1):e202008. doi: 10.21542/gcsp.2020.8.
8
Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Database.肾素-血管紧张素-醛固酮系统抑制剂在肺动脉高压患者中的应用与死亡率：来自退伍军人事务部临床评估报告和跟踪数据库的见解。
Chest. 2021 Apr;159(4):1586-1597. doi: 10.1016/j.chest.2020.09.258. Epub 2020 Oct 5.
9
Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.肺动脉高压患者的肺血管阻力与临床结局：一项回顾性队列研究。
Lancet Respir Med. 2020 Sep;8(9):873-884. doi: 10.1016/S2213-2600(20)30317-9. Epub 2020 Jul 27.
10
The right treatment for the right ventricle.右心室的正确治疗方法。
Curr Opin Pulm Med. 2019 Sep;25(5):410-417. doi: 10.1097/MCP.0000000000000610.
本文引用的文献
1
Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study.组胺H2受体拮抗剂、左心室形态与心力衰竭风险：多族裔动脉粥样硬化研究（MESA）
J Am Coll Cardiol. 2016 Apr 5;67(13):1544-1552. doi: 10.1016/j.jacc.2016.01.045.
2
Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.大型患者队列中边缘性肺动脉高压与死亡率和住院率的关联：来自退伍军人事务部临床评估、报告和跟踪项目的见解
Circulation. 2016 Mar 29;133(13):1240-8. doi: 10.1161/CIRCULATIONAHA.115.020207. Epub 2016 Feb 12.
3
H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study.H2受体拮抗剂与右心室形态：多族裔动脉粥样硬化研究中的右心室研究
Ann Am Thorac Soc. 2014 Nov;11(9):1379-86. doi: 10.1513/AnnalsATS.201407-344OC.
4
Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis.阻断组氨酸 H2 受体通过减少心肌细胞凋亡和纤维化来减缓心力衰竭的进展。
Clin Sci (Lond). 2014 Oct;127(7):435-48. doi: 10.1042/CS20130716.
5
Updated clinical classification of pulmonary hypertension.肺动脉高压的最新临床分类。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. doi: 10.1016/j.jacc.2013.10.029.
6
Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function.组胺 H2 受体激活通过干扰线粒体和内皮功能加重心肌缺血/再灌注损伤。
Basic Res Cardiol. 2013 May;108(3):342. doi: 10.1007/s00395-013-0342-4. Epub 2013 Mar 7.
7
A histamine H₂ receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade.一种组胺 H₂ 受体阻滞剂可改善犬心力衰竭的发展，而与β-肾上腺素能受体阻滞无关。
Basic Res Cardiol. 2010 Nov;105(6):787-94. doi: 10.1007/s00395-010-0119-y. Epub 2010 Sep 18.
8
Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.回顾性和前瞻性随机研究揭示组胺H2受体阻断对慢性心力衰竭的影响。
J Am Coll Cardiol. 2006 Oct 3;48(7):1378-84. doi: 10.1016/j.jacc.2006.05.069. Epub 2006 Sep 14.
9
Accuracy and completeness of mortality data in the Department of Veterans Affairs.美国退伍军人事务部死亡率数据的准确性和完整性。
Popul Health Metr. 2006 Apr 10;4:2. doi: 10.1186/1478-7954-4-2.
10
Mediation of subacute anthracycline cardiotoxicity in rabbits by cardiac histamine release.心脏组胺释放介导家兔亚急性蒽环类药物心脏毒性
J Cardiovasc Pharmacol. 1983 Nov-Dec;5(6):913-9. doi: 10.1097/00005344-198311000-00002.
Zotero 插件